Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02478549
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ZY1 | N-{(1S,2R)-1-benzyl-2-hydroxy-3- [(3-methoxybenzyl)amino]propyl}- 7-ethyl-1-methyl-3,4-dihydro-1H- [1,2,5]thiadiazepino[3,4,5-hi]indole- 9-carboxamide 2,2-dioxide | A | 2WF1 | 0.72 | |
O33 | (4R)-N-[(1S,2R)-2-HYDROXY-2,3-DIHYDRO- 1H-INDEN-1-YL]-3-[(2S,3S)-2-HYDROXY- 3-({N-[(ISOQUINOLIN-5-YLOXY)ACETYL]- S-METHYL-L-CYSTEINYL}AMINO)-4-PHENYLBUTANOYL]- 5,5-DIMETHYL-1,3-THIAZOLIDINE-4- CARBOXAMIDE | B | 2PK6 | 0.72 | |
DRY | [(1-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPYL}- 1H-INDOL-5-YL)OXY]ACETIC ACID | A | 2HWQ | 0.71 | |
DSI | 4-HYDROXY-6-(1H-INDOLE-2-CARBONYL)- 8-METHYL-3,6,7,8-TETRAHYDRO-3,6- DIAZA-AS-INDACENE-2-CARBOXYLIC ACID METHYL ESTER | B | 1DSI | 0.76 | |
V5X | (2R)-N~8~-HYDROXY-2-{[(5-METHOXY- 2-METHYL-1H-INDOL-3-YL)ACETYL]AMINO}- N~1~-[2-(2-PHENYL-1H-INDOL-3-YL)ETHYL]OCTANEDIAMIDE | A,B | 2V5X | 0.75 | |
BIZ | BIZELESIN | B | 226D | 0.74 | |
TRX | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 1K83 | 0.72 | |
TRX | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L, M,T | 2VUM | 0.72 | |
TRX | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 3CQZ | 0.72 | |
FLD | BIS-(N-ETHYLPYRIDINIUM-(3-METHOXYCARBAZOLE))HEXANE- 1,6-DIAMINE | A,B | 154D | 0.7 | |
ZYE | N-{(1S,2R)-1-BENZYL-2-HYDROXY-3- [(3-METHOXYBENZYL)AMINO]PROPYL}- 1-ETHYL-4-(2-OXO-2,3-DIHYDRO-1H- PYRROL-1-YL)-1H-INDOLE-6-CARBOXAMIDE | A | 2WEZ | 0.75 | |
858 | C32-O-(1-ETHYL-INDOL-5-YL)ASCOMYCIN | A,D | 1QPF | 0.75 | |
307 | 6,7-DIMETHYL-3-[(METHYL{2-[METHYL({1- [3-(TRIFLUOROMETHYL)PHENYL]-1H- INDOL-3-YL}METHYL)AMINO]ETHYL}AMINO)METHYL]- 4H-CHROMEN-4-ONE | A,C | 2AZ5 | 0.7 | |
3EA | 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL- 6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | A,B | 2ATH | 0.7 | |
4HT | 4-HYDROXYTRYPTOPHAN | H,L | 1RU9 | 0.72 | |
4HT | 4-HYDROXYTRYPTOPHAN | H,L | 1RUM | 0.72 | |
4HT | 4-HYDROXYTRYPTOPHAN | H,L | 1RUL | 0.72 | |
4HT | 4-HYDROXYTRYPTOPHAN | H,L | 1RUA | 0.72 | |
792 | N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}- 5-methyl-D-tryptophan | A,B,C,D | 3G42 | 0.72 | |
YPA | (S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)- PHENYL)-2-ETHOXY-PROPIONIC ACID | A | 1KNU | 0.71 | |
5PI | N-(ETHYLSULFONYL)-5-PROPOXY-L-TRYPTOPHYL- N~1~-{4-[AMINO(IMINO)METHYL]BENZYL}- L-GLUTAMAMIDE | H,L | 1WV7 | 0.71 | |
ET0 | 3-(5-methoxy-1H-indol-3-yl)propanoic acid | A,B | 3ET0 | 0.73 | |
3LG | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.75 | |
4LG | METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETATE | A,B | 2G27 | 0.75 | |
642 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin- 4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane- 1-carboxylic acid | A,B | 3EWJ | 0.71 | |
A53 | 5-{5-[(S)-2-AMINO-3-(1H-INDOL-3- YL)-PROPOXYL]-PYRIDIN-3-YL}-3-[1- (1H-PYRROL-2-YL)-METH-(Z)-YLIDENE]- 1,3-DIHYDRO-INDOL-2-ONE | A | 2GHG | 0.75 | |
CAU | (2S)-1-(9H-Carbazol-4-yloxy)-3- (isopropylamino)propan-2-ol | A | 2RH1 | 0.7 | |
HTR | BETA-HYDROXYTRYPTOPHANE | A,B | 1QPA | 0.7 | |
HTR | BETA-HYDROXYTRYPTOPHANE | A,B | 1B80 | 0.7 | |
HTR | BETA-HYDROXYTRYPTOPHANE | A | 1ROV | 0.7 | |
6IN | 4-(1-BENZYL-3-CARBAMOYLMETHYL-2- METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID | A | 1DB5 | 0.71 | |
43A | (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)- 3-(1H-PYRROL-2-YLMETHYLENE)-1,3- DIHYDRO-2H-INDOL-2-ONE | A | 2AYP | 0.71 | |
IMS | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1S)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYU | 0.7 | |
IPF | N-ACETYLTRYPTOPHYL-N~1~-{3-[1-(N- ACETYLTRYPTOPHYLVALYL)PYRROLIDIN- 2-YL]-1-BENZYL-2,3-DIHYDROXYPROPYL}VALINAMIDE | A,B | 2A1E | 0.75 | |
587 | C32-O-(1-METHYL-INDOL-5-YL) 18- HYDROXY-ASCOMYCIN | A,C | 1QPL | 0.74 | |
IM8 | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1R)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYE | 0.7 | |
CRR | 3,4-DI-1H-INDOL-3-YL-1H-PYRROLE- 2,5-DICARBOXYLIC ACID | A | 2Z3U | 0.7 | |
330 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4- (2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE- 1,3(2H,6H)-DIONE | A | 2IO6 | 0.7 | |
CP0 | A | 1U65 | 0.71 | ||
IOG | N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]- 2-[2-PHENYL-6-(2-PIPERIDIN-1-YLETHOXY)- 1H-INDOL-3-YL]ACETAMIDE | A | 2IOG | 0.77 | |
RX3 | N-({(1S,2R)-2-[(S)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}- 2-PHENYLETHYL](HYDROXY)PHOSPHORYL]CYCLOPENTYL}CARBONYL)- L-TRYPTOPHAN | A | 2OC2 | 0.73 | |
JTP | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2- D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]- 2-METHYL-L-ALANINE | A,B | 2DXS | 0.71 | |
C80 | (2S,4S,5R,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL 1- BENZYL-1H-INDOLE-3-CARBOXYLATE | C,O | 2V11 | 0.7 | |
DSA | 4-HYDROXY-8-METHYL-6-(4,5,6-TRIMETHOXY- 1H-INDOLE-2-CARBONYL)-3,6,7,8-TETRAHYDRO- 3,6-DIAZA-AS-INDACENE-2-CARBOXYLIC ACID METHYL ESTER | A | 1DSM | 0.74 | |
DSA | 4-HYDROXY-8-METHYL-6-(4,5,6-TRIMETHOXY- 1H-INDOLE-2-CARBONYL)-3,6,7,8-TETRAHYDRO- 3,6-DIAZA-AS-INDACENE-2-CARBOXYLIC ACID METHYL ESTER | B | 1DSA | 0.74 | |
CO9 | 1-({2-[(1S)-1-AMINOETHYL]-1,3-OXAZOL- 4-YL}CARBONYL)-L-PROLYL-L-TRYPTOPHAN | A | 2OPY | 0.74 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX4 | 0.7 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX6 | 0.7 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QWX | 0.7 | |
075 | A | 2PK5 | 0.7 | ||
DRD | 2-[(1-{3-[(6-BENZOYL-1-PROPYL-2- NAPHTHYL)OXY]PROPYL}-1H-INDOL-4- YL)OXY]-2-METHYLPROPANOIC ACID | A | 2HWR | 0.73 | |
PLT | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-L-TRYPTOPHANE | B | 2TYS | 0.71 | |
DUO | 4-HYDROXY-2,8-DIMETHYL-1-OXO-6- (4,5,6-TRIMETHOXY-1H-INDOLE-2-CARBONYL)- 1,2,3,6,7,8-HEXAHYDRO-3,6-DIAZA- AS-INDACENE-2-CARBOXYLIC ACID METHYL ESTER | B | 107D | 0.74 | |
B3C | benzyl [(1R)-1-({(2S,4R)-2-({(1S)- 5-amino-1-[(S)-1,3-benzoxazol-2- yl(hydroxy)methyl]pentyl}carbamoyl)- 4-[(4-methylbenzyl)oxy]pyrrolidin- 1-yl}carbonyl)-3-phenylpropyl]carbamate | B | 3E0P | 0.74 | |
B4C | benzyl [(1S)-5-amino-1-{[(1S)-1- ({(1S)-5-amino-1-[(S)-1,3-benzoxazol- 2-yl(hydroxy)methyl]pentyl}carbamoyl)- 3-phenylpropyl]carbamoyl}pentyl]carbamate | B | 3E16 | 0.71 | |
SA3 | 2,10-DIHYDROXY-12-(BETA-D-GLUCOPYRANOSYL)- 6,7,12,13-TETRAHYDROINDOLO[2,3- A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE | A,C,D | 1SEU | 0.71 | |
CIA | 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL- 2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4- B]INDOLE-1,4-DIONE | A,B | 1UDU | 0.73 | |
CIA | 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL- 2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4- B]INDOLE-1,4-DIONE | A | 1XOZ | 0.73 | |
FRN | A | 2CV3 | 0.73 | ||
KAR | A | 1XA5 | 0.82 | ||
359 | 3-[[3-[(2R)-3-[[(2S)-5-amino-1- [(4-carbamimidoylphenyl)methylamino]- 1,5-dioxo-pentan-2-yl]amino]-2- (ethylsulfonylamino)-3-oxo-propyl]- 1H-indol-5-yl]oxymethyl]benzoic acid | H,L | 2ZZU | 0.71 | |
EHA | (5-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPOXY}- 1H-INDOL-1-YL)ACETIC ACID | A | 2F4B | 0.71 | |
VLB | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)- VINCALEUKOBLASTINE | A,B,C,D | 1Z2B | 0.85 |